A novel NT-proBNP assay for heart failure diagnosis: A prospective, multicenter clinical trial
This novel NT-proBNP assay demonstrated high clinical performance in the diagnosis and exclusion of acute HF in the undifferentiated dyspneic patient and performed similarly well to validated assays used in clinical practice.
Authors
- Jessica Guidi
- W. Franklin Peacock
- Brandon R. Allen (ORCID: https://orcid.org/0000-0003-2577-016X)
- Robert H. Christenson (ORCID: https://orcid.org/0000-0003-2612-9083)
- Dileepa Alahapperuma
- James Louis Januzzi (ORCID: https://orcid.org/0000-0002-8338-1798)
- Gary Headden
- Nicole Winden
Institutions
- University of Maryland, Baltimore (US)
- Medical University of South Carolina (US)
- Baylor College of Medicine (US)
- Brown University (US)
- University of Florida (US)
- Baim Institute for Clinical Research (US)
- Beckman Coulter Foundation (US)
Publication Details
- Journal
- Clinica Chimica Acta
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1016/j.cca.2025.120249
- Citations
- 3
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 4.16